Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s share price rose 2.2% during trading on Monday . The stock traded as high as $8.40 and last traded at $8.34. Approximately 1,025,258 shares were traded during trading, an increase of 86% from the average daily volume of 551,962 shares. The stock had previously closed at $8.16.
Cybin Trading Up 2.2%
The company’s 50 day simple moving average is $6.43 and its 200-day simple moving average is $6.86. The firm has a market cap of $1.24 billion and a P/E ratio of -59.57.
About Cybin
Cybin Inc (OTCMKTS: CLXPF) is a biotechnology company focused on the research, development and commercialization of psychedelic-based therapeutics for the treatment of mental health and wellness disorders. The company leverages proprietary drug discovery platforms to design novel analogues of psilocybin and other psychoactive compounds. Its programs aim to improve the safety, bioavailability and manufacturability of these molecules while addressing conditions such as depression, anxiety and substance use disorders.
Cybin’s pipeline encompasses several clinical and preclinical stage candidates.
See Also
- Five stocks we like better than Cybin
- Wall Street Stockpicker Names #1 Stock of 2026
- Your “birthright claim” just got activated
- The McDonald’s Secret
- Terrifying reason Trump killed the U.S. penny?
- Turn your “dead money” into $306+ monthly (starting this month)
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
